These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19040517)

  • 1. Secondary delusional parasitosis treated with paliperidone.
    Freudenmann RW; Kühnlein P; Lepping P; Schönfeldt-Lecuona C
    Clin Exp Dermatol; 2009 Apr; 34(3):375-7. PubMed ID: 19040517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paliperidone: another treatment option for delusional parasitosis.
    Altınöz AE; Tosun Altınöz Ş; Küçükkarapınar M; Coşar B
    Australas Psychiatry; 2014 Dec; 22(6):576-8. PubMed ID: 25147315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paliperidone extended-release for the treatment of schizophrenia.
    Marino J; Caballero J
    Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy.
    Freudenmann RW; Lepping P
    J Clin Psychopharmacol; 2008 Oct; 28(5):500-8. PubMed ID: 18794644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paliperidone: quo vadis?
    Citrome L
    Int J Clin Pract; 2007 Apr; 61(4):653-62. PubMed ID: 17343660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary delusional parasitosis treated with olanzapine.
    Freudenmann RW; Schönfeldt-Lecuona C; Lepping P
    Int Psychogeriatr; 2007 Dec; 19(6):1161-8. PubMed ID: 17397562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials.
    Janicak PG; Wu JH; Mao L
    Curr Med Res Opin; 2008 Jun; 24(6):1807-15. PubMed ID: 18559166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent.
    Prescrire Int; 2007 Dec; 16(92):236-7. PubMed ID: 18092400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
    Pani L; Marchese G
    Expert Opin Drug Deliv; 2009 Mar; 6(3):319-31. PubMed ID: 19317589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-fatal paliperidone overdose: a case report].
    Gill JS; Pillai SK; Koh OH; Jambunathan S
    Turk Psikiyatri Derg; 2010; 21(4):331-4. PubMed ID: 21125508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
    Kenchaiah BK; Kumar S; Tharyan P
    Int J Dermatol; 2010 Jan; 49(1):95-100. PubMed ID: 20465623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with paliperidone extended-release tablets in a case of resistant undifferentiated schizophrenia: clinical improvement with 12 mg and evaluation through 3TRE scale].
    Rusconi AC; Carlone C; Muscillo M; Piccione M
    Riv Psichiatr; 2009; 44(4):267-72. PubMed ID: 20066799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose pattern and effectiveness of paliperidone extended-release tablets in patients with schizophrenia.
    Lee JS; Ahn JH; Lee JI; Kim JH; Jung I; Lee CU; Lee JY; Lee SI; Kim CY
    Clin Neuropharmacol; 2011; 34(5):186-90. PubMed ID: 21725234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report.
    Angelucci F; Ricci V; Martinotti G; Caltagirone C; Bria P
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1277-8. PubMed ID: 19555731
    [No Abstract]   [Full Text] [Related]  

  • 16. Paliperidone overdose in a patient with schizophrenia.
    Chang JP; Huang CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic treatment of primary delusional parasitosis: systematic review.
    Lepping P; Russell I; Freudenmann RW
    Br J Psychiatry; 2007 Sep; 191():198-205. PubMed ID: 17766758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paliperidone depot: another treatment option for delusional parasitosis.
    Bansal R; Lehmann-Waldau F; McClay J
    Australas Psychiatry; 2015 Jun; 23(3):313-4. PubMed ID: 26014631
    [No Abstract]   [Full Text] [Related]  

  • 19. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
    Jones A
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.